
Nabu a France-based company, has raised €3 million to support its expansion across Europe and strengthen its position in digital customs clearance.
SUMMARY
- Nabu a France-based company, has raised €3 million to support its expansion across Europe and strengthen its position in digital customs clearance.
The round includes participation from Getlink, along with existing investor Maersk Growth.
Nabu, founded in 2022 and based in Paris and Strasbourg offers a platform that automates customs processes for freight forwarders, brokers, and international trade companies. It turns documents into compliant declarations and automated workflows, making cross-border operations easier.
As global trade becomes more complex the need for faster and more efficient customs solutions is growing. Nabu uses AI to reduce manual work while improving speed and accuracy helping teams focus on more important tasks.
RECOMMENDED FOR YOU
DealFlowAgent Raises €646K To Expand AI-Native Investment Bank For SME M&A
Kailee Rainse
Mar 6, 2026
SpinDrive Secures Funding To Scale Magnetic Bearing Technology For A Cleaner, More Efficient Industry
Kailee Rainse
Oct 28, 2025
Read Also - German Mobility Signage Raises €1.8M To Improve Public Transport Systems
Its platform is used by a wide range of clients, from small brokers to large transport companies, with increasing adoption across international markets.
The newly raised capital will help Nabu expand its presence across existing European markets and enter new ones. The company also plans to enhance its platform by improving automation, performance and user experience, while gradually extending its capabilities beyond customs declarations to cover broader cross-border processes.
Every shipment that crosses a border generates considerable administrative complexity. Our ambition is to absorb it and make it manageable, anywhere in the world, in a harmonised, reliable, and transparent way, said Arnaud Doly, CEO and founder of Nabu.
Recommended Stories for You
Wageningen-Based Scope Biosciences Secures Funding For Its CRISPR-Based Molecular Diagnostics Platform
Kailee Rainse Jun 16, 2025






